Evidence map›Paper›PMID 38432989›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Ovarian Microcystic Stromal Tumor with Significant Nestin Expression: A Unique Case.

Bao Wu, Chongming Wu, Dandan Li, Zhanmin Yang, Ying Liu, Hai-Xia Zhang, Hong-Wu Xin, Yuqin Bai

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Ovarian microcystic stromal tumor: a case report and literature review.International journal of clinical and experimental pathology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bao WuDepartment of Histology and Embryology, School of Basic Medicine, Chifeng University, China.
Chongming WuDepartment of Urology, University of Yamanashi, Japan.
Dandan LiDepartment of Pathology, Chifeng Cancer Hospital and The Second Affiliated Hospital of Chifeng University, China.
Zhanmin YangDepartment of Pathology, Chifeng Cancer Hospital and The Second Affiliated Hospital of Chifeng University, China.
Ying LiuLaboratory of Oncology, Center for Molecular Medicine, School of Basic Medicine, Health Science Center, Yangtze University, China.
Hai-Xia ZhangLaboratory of Oncology, Center for Molecular Medicine, School of Basic Medicine, Health Science Center, Yangtze University, China.
Hong-Wu XinLaboratory of Oncology, Center for Molecular Medicine, School of Basic Medicine, Health Science Center, Yangtze University, China.
Yuqin BaiDepartment of Pathology, Chifeng Cancer Hospital and The Second Affiliated Hospital of Chifeng University, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovary microcystic stromal tumor (MCST) is an extremely rare subtype of sex cord-stromal neoplasm, and only 57 cases have been reported. We herein report a unique case of ovarian MCST with positive nestin expression in a 39-year-old Chinese woman. The tumor showed microcystic stromal histological structures and characteristically expressed the CD10, WT-1, and Ki67 proteins. A molecular analysis identified a point mutation (c.110C > T) in exon 3 of the CTNNB1 gene. To our knowledge, no report has described a case of ovarian MCST with positive staining for nestin protein. Our study provides new insights into the tumor biology of ovarian MCST.

Indexed as

NestinOvarian NeoplasmsSex Cord-Gonadal Stromal TumorsAdultbeta CateninFemaleHumansPoint Mutationbeta CateninCTNNB1 protein, humanNES protein, humanNestinhistologyimmunohistochemistrymicrocystic stromal tumor (MCST)nestinovary tumor

Identifiers

PMID38432989
PMCPMC11557199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.